BioTech (Shanghai) Participates in the 2025 Heartland Connect for Trade & Investment Conference!Exploring Long-Term Collaboration with Mayo-Linked DMC to Advance Global Health Innovation

SaniMed
Oct 16, 2025
3 min read

On August 25, 2025, Dr. Jim Wu, Chairman of BioTech (Shanghai) Technology Co., Ltd., was invited to attend the 2025 Heartland Connect for Trade & Investment Conference, hosted by the U.S. Heartland China Association (USHCA).

The event was successfully held in the central United States with strong support from the Chinese General Chamber of Commerce Chicago (CGCCC) and multiple U.S.–China partnership organizations.

This year’s conference focused on three major sectors—Agriculture, Food, and Healthcare—and gathered influential leaders from government, business, academia, and public health to build a high-level platform for local and industrial collaboration between China and the United States.

1️⃣ Opening Ceremony and Keynote Addresses 🎤

The conference opened with a series of high-profile speeches delivered by prominent leaders, including:

Ambassador Xie Feng (video remarks)
Ni Pin, President, CGCCC
Pat Quinn, Former Governor of Illinois
John Atkinson, Chair, Intersect Illinois
Liao Fan, Director, Institute of World Economics and Politics, CASS
Ba Cuicui, Deputy Director, Chinese People’s Association for Friendship with Foreign Countries
Sean Stein, Chair, U.S.-China Business Council
Susan Thornton, Vice Chair, USHCA
Consul General Wang Ling, Consulate General of China in Chicago
Min Fan, Executive Director, USHCA

2️⃣ Healthcare Forum Highlights 💊

The Healthcare Sub-Forum featured in-depth discussions on key topics such as medical equity, patient accessibility, AI in healthcare, and public health collaboration.

Notable speakers and topics included:

Rita Xie, Global Head of Market Access & Policy, Intuitive-Fosun“Expanding Patient Access to Technology and Optimal Care”
Allyson Hansen, CEO, Illinois Medical District“From Environment to Innovation: Building Better Patient Experiences”
Prof. Xi Chen, Associate Professor, Yale University“Global Aging and Health Policy in the Age of AI”
Dr. Zhu Chouwen, Director, Shanghai Clinical Research and Trial Center“Development of China’s Research Hospitals”
Dr. Jianqing Li, Associate Professor, Rush University“Promoting Lung Cancer Screening with LDCT Among Older Chinese American Smokers”
Prof. Xifeng Wu, Dean, National Institute for Health and Medical Data Science, Zhejiang University“Data-Empowered Primary Healthcare Practice and Beyond”
Mayor Kim Norton, City of Rochester, Minnesota“America’s City for Health”
Ross DeVol, Former CEO, Heartland Forward“Maternal Health Outcomes”

3️⃣ BioTech’s Active Participation and Future Collaboration 🤝

As a key representative of cross-border medical technology and healthcare innovation, Jim Wu not only supported the conference’s organization but also held in-depth discussions with Mayor Kim Norton (City of Rochester) and Patrick Seeb (Executive Director, Destination Medical Center – DMC).

The dialogue focused on medical innovation, patient-centered services, and long-term partnership opportunities.

Destination Medical Center (DMC), located in Minnesota, is a globally recognized innovation and investment platform closely aligned with the Mayo Clinic.

Jim Wu and representatives from DMC reached a preliminary consensus to help Chinese healthcare and MedTech companies connect with Mayo Clinic’s global ecosystem, accelerate U.S. market entry, and foster mutually beneficial collaboration between China and the United States in the healthcare sector.

4️⃣ Summary and Key Takeaways 📌

The 2025 Heartland Connect Conference was not only a significant trade and investment event but also a strategic milestone for BioTech (Shanghai).

Through this participation, Jim Wu showcased BioTech’s leading role in cross-border healthcare innovation, laying a solid foundation for future cooperation with Mayo Clinic and DMC.

The event underscored BioTech’s ongoing mission to serve as a bridge for U.S.–China collaboration, promoting medical equity, technological innovation, and global patient well-being.